Das K C, Garewal G, Mohanty D
Acta Haematol. 1980;64(3):121-30. doi: 10.1159/000207224.
Deoxyuridine (dU) suppression test (i.e. ability of exogenous dU to suppress the incorporation of subsequently added 3H-thymidine into DNA) and the incorporation of 3H-thymidine (3H-TdR) alone without dU were studied in bone marrow cultures from 10 patients with erythroleukaemia, 10 patients with vitamin B12/folate-deficient megaloblastic anaemia and 10 haematologically normal subjects. Despite morphological resemblance between megaloblastosis in erythroleukaemia and nutritional megaloblastosis, the dU suppression values in erythroleukaemia were within normal range in contrast to abnormal dU suppression in vitamin B12/folate-deficient megaloblastic bone marrows. The incorporation of 3H-thymidine alone was significantly lower in erythroleukaemia than in normal or vitamin B12/folate-deficient megaloblastic bone marrows. Autoradiographic studies showed that 3H-TdR labelling indices as well as mean grain count (MGC) of basophilic and polychromatic erythroblasts were significantly lower in erythroleukaemia than in normal or vitamin B12/folate-deficient bone marrows. The reduced incorporation of 3H-TdR in erythroleukaemia erythroblasts was probably not due to deficiency of the salvage pathway enzyme, thymidine kinase, since MTX (10(-5) M) which blocks the de novo pathway of thymine-DNA synthesis, enhanced the incorporation of 3H-TdR into erythroblasts in erythroleukaemia as well as in normal bone marrows. A high intracellular pool of thymidine-triphosphate (dTTP) due to defective DNA synthesis may allosterically inhibit thymidine kinase and 3H-TdR incorporation.
在10例红白血病患者、10例维生素B12/叶酸缺乏的巨幼细胞贫血患者和10例血液学正常的受试者的骨髓培养物中,研究了脱氧尿苷(dU)抑制试验(即外源性dU抑制随后添加的3H-胸腺嘧啶核苷掺入DNA的能力)以及单独添加3H-胸腺嘧啶核苷(3H-TdR)而不添加dU的情况。尽管红白血病中的巨幼样变与营养性巨幼细胞贫血在形态上相似,但红白血病中的dU抑制值在正常范围内,而维生素B12/叶酸缺乏的巨幼细胞性骨髓中的dU抑制异常。单独添加3H-胸腺嘧啶核苷时,红白血病中的掺入量显著低于正常或维生素B12/叶酸缺乏的巨幼细胞性骨髓。放射自显影研究表明,红白血病中嗜碱性和多色性成红细胞的3H-TdR标记指数以及平均颗粒计数(MGC)显著低于正常或维生素B12/叶酸缺乏的骨髓。红白血病成红细胞中3H-TdR掺入减少可能不是由于补救途径酶胸苷激酶缺乏,因为阻断胸腺嘧啶-DNA合成从头途径的甲氨蝶呤(MTX,10^(-5) M)增强了3H-TdR在红白血病和成红细胞以及正常骨髓中的掺入。由于DNA合成缺陷导致的细胞内三磷酸胸苷(dTTP)高池可能会变构抑制胸苷激酶和3H-TdR掺入。